Phase 1 Ischaemic Stroke Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Completed

Phase 1

Trial of Amnion Cell Therapy for Ischaemic Stroke (I-ACT)

Ischaemic Stroke

Prof Thanh Phan8 enrolled1 locationACTRN12618000076279

Completed

Phase 1

A Study to Assess the Safety, Tolerability and Effects of Compound Edaravone Injection (Edaravone + Borneol).

This study involves recruiting healthy subjects to trial a drug intended to treat Ischaemic Stroke.

Medpace Australia Pty Limited48 enrolled1 locationACTRN12611000228987